ALK重排晚期非小细胞肺癌对克唑替尼耐药的分子特征
邓秋梅， 王涵敏， 康劲， 杨衿记 - 循证医学, 2021 - jebm.cn
… important driver gene of non⁃small⁃cell lung cancer(NSCLC),… a total of 234 patients with
ALK⁃positive advanced NSCLC … 44 patients with advanced ALK⁃rearranged NSCLC treated …
ALK⁃positive advanced NSCLC … 44 patients with advanced ALK⁃rearranged NSCLC treated …
[HTML][HTML] 晚期ALK 融合阳性非小细胞肺癌治疗全程管理1 例
白赫男， 韩雨， 牛意， 张明晖 - Chinese Journal of Lung Cancer, 2021 - ncbi.nlm.nih.gov
… This paper reports the treatment of a late stage non-small cell lung cancer (NSCLC) patient
… Since September 4, 2019, oral administration of nsatinib has been carried out. As of March 1…
… Since September 4, 2019, oral administration of nsatinib has been carried out. As of March 1…
[HTML][HTML] 布格替尼治疗ALK 阳性NSCLC 患者期间相关早发性肺事件及其管理策略
Y Mingyi, LUO Weichi, Z Qing - Chinese Journal of Lung Cancer, 2023 - ncbi.nlm.nih.gov
… rearrangements occur in non-small cell lung cancer (NSCLC)… a treatment for locally advanced
or metastatic NSCLC patients … , and management strategies of EOPEs to provide clinicians …
or metastatic NSCLC patients … , and management strategies of EOPEs to provide clinicians …
间变性淋巴瘤激酶抑制剂的研究进展
陈雅琳， 李巍， 汪天洋， 周雪琴， 刘东志 - 化工进展, 2016 - hgjz.cip.com.cn
… Drug Administration(FDA)approved it for treating ALK-positive … treatment in advanced
ALK-positive non–small-cell lung … in patients with ALK-positive non-small-cell lung cancer : …
ALK-positive non–small-cell lung … in patients with ALK-positive non-small-cell lung cancer : …
肺肉瘤样癌术后迅速多发转移行免疫联合治疗1 例
蒋振江， 张媛， 李东辉 - 循证医学, 2022 - jebm.cn
… carcinoma,PSC)是一种少见,分化较差的非小细胞肺癌(non⁃ small cell lung cancer,NSCLC),…
the main comprehensive treatment,however,those who cannot be resected are treated mainly …
the main comprehensive treatment,however,those who cannot be resected are treated mainly …
[HTML][HTML] 克里唑替尼治疗晚期非小细胞肺癌的临床研究进展
朱海波， 徐小玉， 王玲 - Chinese Journal of Lung Cancer, 2013 - ncbi.nlm.nih.gov
… At present, in the treatment of non-small cell lung cancer (… ) in patients with ALK-positive
non-small cell lung cancer (… in advanced ALK-positive non-small cell lung cancer (NSCLC): …
non-small cell lung cancer (… in advanced ALK-positive non-small cell lung cancer (NSCLC): …
[HTML][HTML] 中晚期非小细胞癌类型患者新辅助治疗的研究现状
刘毅， 朱冰 - Advances in Clinical Medicine, 2023 - hanspub.org
… current status of neoadju-vant therapy research for intermediate and advanced non-small cell
lung cancer … This article mainly reviews the progress of neoadjuvant treatment for patients …
lung cancer … This article mainly reviews the progress of neoadjuvant treatment for patients …
[HTML][HTML] 不同二代ALK -TKIs二线治疗ALK阳性晚期非小细胞肺癌的耐药基因变异分子图谱差异
丁宁， 徐晓波， 周洁白， 张勇， 刘子龙， 刘洁， 张东辉… - 2022 - aammt.tmmu.edu.cn
… evidence for the management of ALK fusion positive advanced non-small cell lung cancer
(… Therefore, the clinical treatment decisions of advanced NSCLCs with ALK positive should …
(… Therefore, the clinical treatment decisions of advanced NSCLCs with ALK positive should …
[HTML][HTML] 非小细胞肺癌驱动基因的研究
曹涤非， 薛佳莹， 黄国庆 - Hans Journal of Biomedicine, 2021 - hanspub.org
… for cancer. At present, there are some clinically targeted drugs of non-small cell lung cancer,
… the mechanism and clinical treatment of driver genes in non-small cell lung cancer, in order …
… the mechanism and clinical treatment of driver genes in non-small cell lung cancer, in order …
[HTML][HTML] CDK4/6 抑制剂在非小细胞肺癌治疗中的研究进展
秦琼， 任尧尧， 钟殿胜 - Chinese Journal of Lung Cancer, 2020 - ncbi.nlm.nih.gov
… achieved some results, which may become a new treatment in the future. This review focuses
… 其中非小细胞肺癌（non-small cell lung cancer, NSCLC）占80%-85%，并且很大一部分患者…
… 其中非小细胞肺癌（non-small cell lung cancer, NSCLC）占80%-85%，并且很大一部分患者…